FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
Executive Summary
The pharmaceutical industry's long-term goal in counterfeit prevention should be to have all drug products contain an "electronic pedigree," FDA's Counterfeit Drug Task Force interim report says
You may also be interested in...
NACDS Anti-Counterfeit Proposal Would Use “One Forward/One Back” Model
FDA should require distributors to adopt a "one forward/one back" record keeping system for drug sales to prevent counterfeiting, the National Association of Chain Drug Stores recommended
NACDS Anti-Counterfeit Proposal Would Use “One Forward/One Back” Model
FDA should require distributors to adopt a "one forward/one back" record keeping system for drug sales to prevent counterfeiting, the National Association of Chain Drug Stores recommended
FDA Counterfeit Drug Website “Icon” Considered For Education Campaign
The FDA Counterfeit Drug Task Force's public education subcommittee may develop an "icon" that would allow anti-counterfeiting collaborators' websites to link to an online FDA reference page